Idexx Laboratories | IDXX - Current Liabilities

Stock Price
639.60
Daily Change
-30.86 -4.60%
Monthly
-6.25%
Yearly
36.36%
Q1 Forecast
649.81

Idexx Laboratories reported $1.25B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Align Technology USD 1.97B 29.02M Sep/2025
Dentsply International USD 1.4B 239M Sep/2025
Dexcom USD 3.34B 27.3M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Fujifilm JPY 1.16T 95.09B Sep/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Henry Schein USD 3.15B 142M Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Idexx Laboratories USD 1.25B 27.93M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
Masimo USD 369.7M 222.4M Sep/2025
Neogen USD 147.05M 850K Sep/2025
ResMed USD 1.25B 7.39M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Steris USD 888.9M 37.7M Sep/2025
Tandem Diabetes Care USD 252.54M 852K Sep/2025
Teleflex USD 773.03M 56.88M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Zoetis USD 1.81B 1.56B Sep/2025